Jiangsu Bioperfectus Technologies Co., Ltd.

Equities

688399

CNE1000055B2

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 23:00:00 07/05/2024 BST 5-day change 1st Jan Change
75.06 CNY +0.27% Intraday chart for Jiangsu Bioperfectus Technologies Co., Ltd. +2.21% +37.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Bioperfectus Technologies Gets Nod to Register Hepatitis B Detection Kit MT
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jiangsu Bioperfectus Technologies Co., Ltd.(XSSC:688399) dropped from S&P Global BMI Index CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Bioperfectus Elects Chairman, General Manager MT
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Bioperfectus Technologies Co., Ltd.(XSSC:688399) added to S&P Global BMI Index CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Test makers target monkeypox market as cases surge RE
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiangsu Bioperfectus Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart Jiangsu Bioperfectus Technologies Co., Ltd.
More charts
Jiangsu Bioperfectus Technologies Co Ltd is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The Company mainly conducts its businesses in domestic and overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 688399 Stock
  4. News Jiangsu Bioperfectus Technologies Co., Ltd.
  5. Bioperfectus Technologies Gets Nod to Register Hepatitis B Detection Kit